Loading
Genix Pharmaceuticals Corporation Stock: price and insider trades · Canada
CA·Mcap CA$1.2M
Genix Pharmaceuticals Corporation: what insiders have been doing
Every trade that managers of Genix Pharmaceuticals Corporation disclose to SEDI is tracked on this page. The last twelve months, up to 18 October 2026, brought 12 filings signed by 3 insiders.
Both sides are active: 1 purchase and 6 sales, from 1 insider and 1 insider respectively. The amount is not disclosed for 7 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 senior executive.
Compared with its exchange (2,144 companies, median 12 filings), a count of 12 filings is typical. Since 2020, the database holds 1 purchase and 6 sales by insiders of the company.
The last purchase on record was published on 8 September 2026, which is 39 days ago. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
6 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended October 2025 · cache
CA$0.02
Analyst consensus
Income statement
EBITDA-CA$161.8k
Net income-CA$335.1k0.0% margin
Valuation
Beta0.43
Balance sheet & cash
Market capCA$1.2M
Total debtCA$1M
Free Cash Flow-CA$124.1k
Profitability & ownership
ROA-177.4%
% insiders46.9%
% institutions0.0%
Last declaration on 8 September 2026
Declarations13 total
50,000 sharesOptionsTSXSEDI:4775117
300,000 sharesOptionsTSXSEDI:4775115
4,000 sharesCommon SharesTSXSEDI:4775109
200 sharesCommon SharesTSXSEDI:4775108
Canonical exit: 4 Oct 2022 (T+90)
12,500 sharesCommon SharesTSXSEDI:4775107
5,000 sharesCommon SharesTSXSEDI:4775106
30,000 sharesCommon SharesTSXSEDI:4775104
400,000 sharesCommon SharesTSXSEDI:4775103
400,000 sharesCommon SharesTSXSEDI:4775101
50,000 sharesOptionsTSXSEDI:4766736
50,000 sharesOptionsTSXSEDI:4766735
Common SharesTSXSEDI:4757458
13 of 13 declarations
About Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corporation is a company focused on developing innovative pharmaceuticals. It is listed on the Toronto Stock Exchange (XTSE).
